PROLOR BIOTECH
PROLOR Biotech is developing proprietary versions of already-approved therapeutic proteins. The Company’s Carboxyl Terminal Peptide technology can be attached to an array of existing therapeutic proteins, stabilizing the therapy in the bloodstream and extending its lifespan without additional toxicity or loss of desired biological activity. PROLOR products under development include Human Growth Hormone (“hGH”) for the long-term treatment of children and adults with growth failure due to inadequate secretion of endogenous growth hormone (a $3 billion market opportunity). PROLOR’s hGH could potentially be injected once a week or twice per month instead of daily. PROLOR’s hGH is scheduled for Phase III trials in 2013.
PROLOR BIOTECH
Social Links:
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2001-01-01
Address:
Nes Ziyona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.prolor-biotech.com
Total Employee:
51+
Status:
Active
Contact:
866 644 7811
Email Addresses:
[email protected]
Total Funding:
56.4 M USD
Technology used in webpage:
SPF Amazon GoDaddy DNS AWS Global Accelerator AppRiver
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Onegene Biotechnology
Onegene Biotechnology develops highly potent tri- or intraspecific protein-based drugs.
Founder
Investors List
SternAegis
SternAegis investment in Venture Round - PROLOR Biotech
Official Site Inspections
http://www.prolor-biotech.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
